Medicamen Biotech Ltd
MEDICAMEQMedicamen Biotech Ltd
MEDICAMEQPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
63.58 | 3.81 | 0.17% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.69 | 5.96 | 0.57% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
MEDICAMEN Biotech is engaged in manufacturing of pharmaceutical formulations.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | — | — | — | — | 126.26 | 127.44 | 113.47 | 117.17 | 143.33 | 172.75 | ||||||||||
Raw Materials | — | — | — | — | 81.95 | 80.45 | 68.42 | 55.69 | 81.80 | 147.68 | ||||||||||
Power & Fuel Cost | 2.11 | 2.90 | 2.68 | 5.86 | 5.67 | |||||||||||||||
Employee Cost | 8.09 | 9.52 | 9.00 | 14.50 | 20.15 | |||||||||||||||
Selling & Administrative Expenses | 5.30 | 5.16 | 4.14 | 7.79 | 7.90 | |||||||||||||||
Operating & Other expenses | 7.69 | 8.00 | 8.80 | 7.51 | 1.00 | |||||||||||||||
EBITDA | — | — | — | — | 21.12 | 21.41 | 20.43 | 25.82 | 26.81 | 25.07 | ||||||||||
Depreciation/Amortization | — | — | — | — | 2.21 | 2.50 | 2.52 | 5.77 | 6.37 | 6.93 | ||||||||||
PBIT | — | — | — | — | 18.91 | 18.91 | 17.91 | 20.05 | 20.44 | 18.14 | ||||||||||
Interest & Other Items | — | — | — | — | 1.38 | 0.93 | 1.51 | 1.94 | 3.39 | 3.38 | ||||||||||
PBT | — | — | — | — | 17.53 | 17.98 | 16.40 | 18.11 | 17.05 | 14.76 | ||||||||||
Taxes & Other Items | — | — | — | — | 5.50 | 4.69 | 4.27 | 3.20 | 2.20 | 3.17 | ||||||||||
Net Income | — | — | — | — | 12.03 | 13.29 | 12.13 | 14.91 | 14.85 | 11.59 | ||||||||||
EPS | — | — | — | — | 10.28 | 11.11 | 9.93 | 12.20 | 11.94 | 9.16 | ||||||||||
DPS | — | — | — | — | 1.00 | 0.50 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||||
Payout ratio | — | — | — | — | 0.10 | 0.04 | 0.10 | 0.08 | 0.08 | 0.11 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Medicamen Biotech Ltd | 49.63 | 3.81 | 0.17% |
Sun Pharmaceutical Industries Ltd | 42.53 | 6.08 | 0.77% |
Cipla Ltd | 40.34 | 4.77 | 0.61% |
Dr Reddy's Laboratories Ltd | 22.92 | 4.44 | 0.64% |
Price Comparison
Compare MEDICAMEQ with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.60%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
Dividend Yield
Current dividend yield is 0.17%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.72 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 20, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateSep 17, 2020
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2020
Cash Dividend
Ex DateEx DateSep 17, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2019
News & Opinions
Medicamen Biotech’s USFDA filing sparks 5.12 per cent surge in shares
9 months ago•The Hindu Businessline
Medicamen Biotech gains on successful ANDA filing for Bortezomib injections
9 months ago•Moneycontrol
Medicamen Biotech announces debut in domestic pharma sector
1 year ago•India Infoline
Aarvee Denims & Exports Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
Medicamen Biotech signs CDMO agreement with Vital Pharma Nordic
1 year ago•Business Standard
Medi Caps gets approval under RERA for Real Estate Project ‘Medicaps Business Park’
2 years ago•India Infoline
This smallcap pharmaceutical stock has zoomed 62% thus far in December
2 years ago•Business Standard
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant